00032-X/asset/f312f4e3-50d1-472f-90c9-896e4cef8e23/main.assets/gr1_lrg.jpg)
tirzepatide chronic kidney disease trial A comparison of the effects of and dulaglutide on major events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT Tirzepatide reduces albuminuria among adults
Description
Currently available in Ontario, BC, Alberta, Manitoba, Saskatchewan, New Brunswick, Newfoundland, Nova Scotia, and PEI
International Journal of Diabetes and Endocrinology, 10 (2), 3744
Both are administered as weekly self-injections in LIV Body's program per brand materials
Youre Still Taking a Starter Dose One of the most common reasons people arent losing weight on tirzepatide is that theyre still on the introductory dose
A November 2025 inspection found contamination in a drug-preparation area tied to a batch of testosterone that was subsequently pulled from the market
